AI assistant
Immuron Ltd — Regulatory Filings 2008
Sep 18, 2008
35121_rns_2008-09-18_3095be24-4b5f-4065-8057-c15072a3f2df.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [186 x 44] intentionally omitted <==
Anadis and Tatura Milk Industries collaborate to take on export markets
Friday 19 September 2008
In light of recent successes in negotiating sale of Anadis based products into markets in USA and Asia, Anadis and Tatura Milk Industries (TMI) are co‐operating to increase the volume of colostrums product leaving Australia.
TMI, a large Goulburn Valley based dairy company, is a major shareholder in Anadis Limited and is assisting the increased commercialisation push with manufacturing systems, market development input and export logistics management. As regulatory and distribution hurdles are being overcome, exports markets are expected in the short term in Asia, USA and Europe. Anadis and TMI are also combining to develop a range of high volume products for TMI’s major clients in Asia.
“These new orders will consume our current product stockpiles quickly and they need to be replaced to meet demand. Our alliance with TMI will assist us grow our commercialisation effort into profit.” said Dr Zeil Rosenberg, Anadis CEO.
Aidan Coleman, CEO of Tatura Milk Industries, says – “As a major shareholder of Anadis and as a specialised dairy ingredients company we will assist Anadis in its growth phase. I am sure there will be an increasing collaboration between the two companies and I look forward to further commercial success”.
For further information contact:
Dr. Zeil Rosenberg ‐ CEO Email: [email protected] Tel: +1 646 402 5289
Dr. Oren Fuerst‐ VP, Business Development Email: [email protected] Tel +1 646 259 3321
Gran Rawlin – VP, Research and Development Email: [email protected] Tel: +61 3 9018 4880
AUSTRALIA 4 Capital Link Drive, Campbellfield, VICTORIA, 3061 Tel (61) 3 9358 6388 Fax (61) 3 9358 6399
USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118 Tel 646 402 5289 Fax 646 390 3238
www.anadis.com www.travelan.com
==> picture [186 x 44] intentionally omitted <==
Arie Nudel‐ Investor Relations Email: [email protected] Tel: +61 3 9014 4880
Anadis Limited (ASX: ANX; OTC: ANDIY) is a biopharmaceutical company focused on antigen‐primed, dairy‐derived health products. Anadis’ proprietary technology enables it to rapidly develop polyclonal antibody and other proteins‐based solutions to a range of important diseases. The all‐natural colostrum‐derived platform, its high safety profile when administered orally and the proprietary methods of manufacturing, allows for short time‐frame from bench to market with high manufacturing scalability.
AUSTRALIA 4 Capital Link Drive, Campbellfield, VICTORIA, 3061 Tel (61) 3 9358 6388 Fax (61) 3 9358 6399
USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118 Tel 646 402 5289 Fax 646 390 3238